NCT00243685View on ClinicalTrials.gov

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

May 31, 2009

Conditions
Breast NeoplasmsLung NeoplasmsOvarian NeoplasmsSarcoma, Soft Tissue
Interventions
OTHER

Laboratory Assay

Chemotherapy

OTHER

Mick Assay

Chemotherapy doctor determined from results

Trial Locations (3)

37203

Nashville Breast Center, Nashville

Nashville Oncology Associates, Nashville

78229

Cancer Care Centers of South Texas, San Antonio

Sponsors
All Listed Sponsors
lead

Pierian Biosciences

INDUSTRY